Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human... see more

TSXV:CZO - Post Discussion

Ceapro Inc > S&P Biotech ETF
View:
Post by prophetoffactz on Mar 14, 2024 11:57am

S&P Biotech ETF

S&P Biotech ETF is suddenly down about 9% from its high within the last month. Did Gilles manage to secure cash with the merger ahead of a potential inflation scare that could crush biotech stocks once again? The markets were expecting declining inflation and interest rates which is good for pre-revenue biotech. Was the market wrong as inflation data has been disapoining to the upside? CZO needs a well targeted investment program to make sure it leads to sustainability until the inflation issue is resolved.


 @PeterSchiff
Both bond yields and #oil prices are on the rise. 30-year yields are back above 4.4% headed to 5% and oil is back above $80 headed to $100. These trends fly in the face of the #Fed excepting to hit its 2% #inflation target and its intention to substantially reduce interest rates.
Comment by prophetoffactz on Mar 14, 2024 12:39pm
As markets worry about higher inflation the toll of inflation and interest rate hikes may finally be hitting the consumer. How much does Aveeno and Neutrogena, etc. target the low end consumer?  @DiMartinoBooth · 2m  ...more  
Comment by prophetoffactz on Mar 14, 2024 12:50pm
US headline inflation bottomed 8 months ago above the US Federal Reserves target...
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities